Lesley Ann Calhoun, Director at Tango Therapeutics, Inc. (TNGX), sold 5,000 shares at $7.21 ($36K) on 2024-06-05, disclosed to the SEC on 2024-06-07.
Scheduled sale ($36k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GBT | SELL | 2020-05-13 | $498K | — | Filing → |
| GBT | SELL | 2019-09-13 | $301K | — | Filing → |
| GBT | SELL | 2019-02-14 | $18K | — | Filing → |